4.8 • 3.6K Ratings
🗓️ 1 May 2025
⏱️ 11 minutes
🧾️ Download transcript
Click on a timestamp to play from that location
| 0:00.0 | We ask a lot of questions about our diet. |
| 0:03.0 | What's the right way to treat a chronic illness, fight off a virus, lose weight? |
| 0:09.0 | The problem is we get a lot of different answers. |
| 0:12.0 | Well, I'm here to help. |
| 0:14.0 | Welcome to the Nutrition Facts podcast. |
| 0:16.0 | I'm your host Dr. Michael Greger. |
| 0:19.0 | Today, in part three of our series on OZMPIC, we look at how to control the side effects |
| 0:23.6 | of GLP1 drugs. |
| 0:25.6 | It appears the vast majority of people prescribed GLP1 drugs stopped taking them in a matter |
| 0:30.6 | of months, but compare that to the older weight loss drugs. |
| 0:34.6 | Those had a 98% failure rate. In drug trials, most people taking these types of weight-loss drugs. Those had a 98% failure rate. |
| 0:38.0 | In drug trials, most people taking these types of weight-loss drugs started out obese and |
| 0:42.3 | ended up obese no matter how long they stayed on them. |
| 0:45.3 | But that's just on average. |
| 0:46.8 | Some people, despite being on high-dose-ozympic for years, actually ended up heavier than |
| 0:51.8 | when they started, and most remained overweight, but |
| 0:55.1 | a small fraction, some about 1 in 25, plateaued down at a normal weight. |
| 1:01.4 | 1 in 25 doesn't sound like a lot, but obese individuals are rarely able to achieve |
| 1:05.9 | a normal weight without something drastic like bariatric surgery. |
| 1:10.0 | Only about 1 in 200 men with |
| 1:11.5 | class 1 obesity or 1 in 100 women, are able to find their way back to a normal weight, |
| 1:16.7 | so these drugs really can have a huge effect in a select few. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from [email protected], and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of [email protected] and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.